Physician profile
Kellie Rose
NPI 1336174499
$2,087.89
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $463 · 2021: $590 · 2022: $545 · 2023: $182 · 2024: $31.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $545.38 | 2019-2023 | Xarelto |
| Argon Medical Devices, INC. | $315.30 | 2020 | |
| Medtronic, INC. | $278.30 | 2021-2022 | |
| Artivion, INC. | $264.18 | 2022-2023 | Vascular |
| Acell, INC. | $165.62 | 2019 | |
| Pfizer INC. | $85.17 | 2019-2023 | |
| Philips North America LLC | $69.26 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $64.58 | 2021-2022 | |
| Mozarc Medical US LLC | $53.32 | 2023 | Palindrome |
| Angiodynamics, INC. | $43.07 | 2021 | |
| Integra Lifesciences Corporation | $40.44 | 2021-2022 | |
| Nevro Corp. | $36.39 | 2023 | Senza |
| Becton, Dickinson and Company | $31.78 | 2024 | Lutonix Drug Coated Balloon |
| Davol INC. | $30.50 | 2020 | |
| Getinge USA Sales, LLC | $24.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $23.90 | 2021 | |
| Elutia, INC. | $16.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.